Truist Securities Downgrades Cargo Therapeutics to Hold, Lowers Price Target to $7
Author: Benzinga Newsdesk | January 30, 2025 10:50am
Truist Securities analyst Asthika Goonewardene downgrades Cargo Therapeutics (NASDAQ:CRGX) from Buy to Hold and lowers the price target from $32 to $7.